Toll-Like Receptor Signaling in Endothelial Cell Inflammation

Toll-like receptors (TLRs) are innate immune sensors expressed on vascular endothelial cells that detect both pathogen-associated molecular patterns and endogenous damage signals. Engagement of TLRs on the endothelial surface triggers adaptor-mediated cascades, chiefly through MyD88-dependent and TRIF-dependent pathways, leading to activation of transcription factors such as NF-κB and interferon regulatory factors. This drives the expression of pro-inflammatory cytokines, chemokines and adhesion molecules, promoting leukocyte recruitment, increased vascular permeability and endothelial dysfunction. Beyond classic microbial recognition, endothelial TLR signalling responds to sterile stressors in atherosclerosis, ischaemia-reperfusion injury and sepsis. Emerging studies have characterised cell-type-specific regulation of TLR expression, spatiotemporal control of TLR activation and the interplay between TLRs and other vascular signalling networks, offering insights into targeted modulation of vascular inflammation.

Research from Nature Portfolio

One study of brain microvascular endothelium has revealed that distinct TLR ligands produce dichotomous effects on barrier integrity: both TLR3 and TLR4 agonists induced cytokine release and transient barrier disruption, whereas an imidazoquinoline compound strengthened the barrier via a non-canonical receptor pathway. This work highlights tissue-specific variation in endothelial TLR repertoires and uncovers potential anti-inflammatory receptor targets in the central nervous system vasculature.

In a preclinical model of autoimmune diabetes, pharmacological blockade of TLR4 signalling with a selective inhibitor reduced CD4+ T-cell activation, diminished insulitic infiltration and prevented onset of hyperglycaemia. These findings demonstrate that endothelial TLR4 not only mediates local cytokine networks but also influences antigen-driven adaptive immunity, underscoring the receptor’s role in systemic inflammatory disease.

Toll-Like Receptor Signaling in Endothelial Cell Inflammation publication trend

The graph below shows the total number of articles in toll-like receptor signaling in endothelial cell inflammation across all publications each year (not limited to Nature Index journals).

Technical terms

Toll-like Receptor (TLR): A membrane-bound sensor that recognises conserved microbial or damage-associated motifs and initiates innate immune signalling.

Pathogen-Associated Molecular Pattern (PAMP): A conserved microbial structure recognised by innate immune receptors.

Damage-Associated Molecular Pattern (DAMP): An endogenous molecule released by stressed or dying cells that activates innate immunity.

NF-κB: A transcription factor central to the induction of pro-inflammatory genes following receptor stimulation.

MyD88: An adaptor protein that recruits kinases to TLRs, driving rapid inflammatory gene expression.

TRIF: An alternative adaptor that links certain TLRs to interferon regulatory factor activation and late-phase cytokine production.

Optogenetics: A technique that uses light-sensitive protein domains to control cellular signalling with high temporal and spatial precision.

References

1. Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions. Frontiers in Immunology (2023).
2. Comparative and Temporal Characterization of LPS and Blue-Light-Induced TLR4 Signal Transduction and Gene Expression in Optogenetically Manipulated Endothelial Cells. Cells (2023).
3. The functional and inflammatory response of brain endothelial cells to Toll-Like Receptor agonists. Scientific Reports (2018).
4. Toll-like receptor 4 inhibition prevents autoimmune diabetes in NOD mice. Scientific Reports (2019).